Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2022-08-11), Medtronic's Intrinsic Value: Projected FCF is $68.66. The stock price of Medtronic is $94.17. Therefore, Medtronic's Price-to-Intrinsic-Value-Projected-FCF of today is 1.4.
The historical rank and industry rank for Medtronic's Intrinsic Value: Projected FCF or its related term are showing as below:
MDT'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.78 Med: 1.89 Max: 6.91
Current: 1.37
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Medtronic was 6.91. The lowest was 0.78. And the median was 1.89.
MDT's Price-to-Projected-FCF is ranked better than 64.69% of 320
companies
in the Medical Devices & Instruments industry
Industry Median: 1.79
vs MDT: 1.37
Medtronic Intrinsic Value: Projected FCF Historical Data
The historical data trend for Medtronic's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Medtronic Annual Data
Trend
Apr13
Apr14
Apr15
Apr16
Apr17
Apr18
Apr19
Apr20
Apr21
Apr22
Intrinsic Value: Projected FCF
65.40
68.09
66.12
66.03
68.66
Medtronic Quarterly Data
Jul17
Oct17
Jan18
Apr18
Jul18
Oct18
Jan19
Apr19
Jul19
Oct19
Jan20
Apr20
Jul20
Oct20
Jan21
Apr21
Jul21
Oct21
Jan22
Apr22
Intrinsic Value: Projected FCF
66.03
65.30
66.67
68.19
68.66
Competitive Comparison
For the Medical Devices subindustry, Medtronic's Intrinsic Value: Projected FCF, along with its competitors' market caps and Intrinsic Value: Projected FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic Intrinsic Value: Projected FCF Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Intrinsic Value: Projected FCF distribution charts can be found below:
* The bar in red indicates where Medtronic's Intrinsic Value: Projected FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Medtronic's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
94.17
/
68.655112174674
=
1.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medtronic Intrinsic Value: Projected FCF Related Terms
Thank you for viewing the detailed overview of Medtronic's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.07(1.15%) Volume: 4,337,055 10:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MDT has been successfully added to your 
